These abnormalities can then be used to predict the binding affinity of mutated proteins to MHC molecules through computational approaches, and assist in the selection of optimal vaccine compositions for each individual.[23] Time is also a primary concern when analyzing samples as it is desirable to minimize the time between the acquisition of the tumor biopsy and the administration of therapy. Here, HLA-C is linked to neoplasm.